Clinical Trials Logo

Osteoma, Osteoid clinical trials

View clinical trials related to Osteoma, Osteoid.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT02739555 Terminated - Osteoid Osteoma Clinical Trials

Zoledronic Acid Compared to Percutaneous Treatment in Osteoid Osteoma

BISPHOO
Start date: June 23, 2016
Phase: Phase 3
Study type: Interventional

Osteoid osteoma (OO) is a benign osteogenic tumor occurring in children and young adults, responsible for intense bone pain, which has a tendency to spontaneously heal with mineralization of the nidus, but extremely slowly. This healing may be accelerated in patients taking NSAIDs regularly during a few years. The long delay for healing and intense pain, explain why patients are quickly directed to surgeons or specialized radiology departments for tumor ablation. But percutaneous treatment or surgical excision destruction can expose the patient to a substantial risk in terms of neurologic or joint damages, depending on the location. Bisphosphonates treatment may be an effective alternative to percutaneous treatment by accelerating the natural history of OO.